Skip to content
Disclosery

13F-HR filed by Medicxi Ventures Management (Jersey) Ltd

Medicxi Ventures Management (Jersey) Ltd filed this 13F-HR for the quarter ended 2026-06-30, filed 2026-08-04, with 3 holding rows worth $177,424,615.

Accession
0001193125-26-332000
Filer
CIK 1715579
Filed
2026-08-04
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2026

A holdings report, 3 entries on the cover page, a total value of $177,424,615 stated on the cover page (in dollars after the unit check, H1), rows summing to $177,424,615 with VALUE read as dollars as filed, 13F file number 028-19833. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerDe Rubertis Francesco 028-19836

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PHATHOM PHARMACEUTICALS INC71722W107COMMON STOCK7,464,572$80,990,606dollars as filed
NEWAMSTERDAM PHARMA CO NVN62509109COMMON STOCK2,208,639$74,850,776dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK3,039,892$21,583,233dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001193125-26-332000this filing2026-08-04acceptance time not in the bulk data set